| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0009-8981(01)00679-9 |
| P698 | PubMed publication ID | 11718702 |
| P50 | author | Klaus Jung | Q56956220 |
| P2093 | author name string | M Lein | |
| C Laube | |||
| R Lichtinghagen | |||
| P2860 | cites work | Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 |
| Role of matrix metalloproteinases in normal and disease processes | Q33985677 | ||
| Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma | Q68499805 | ||
| Software for illustrative presentation of basic clinical characteristics of laboratory tests--GraphROC for Windows | Q71767755 | ||
| Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays | Q72722726 | ||
| Matrix metalloproteinase-9 in peripheral blood eosinophils | Q73102192 | ||
| Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer | Q73509443 | ||
| Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers | Q73571853 | ||
| Circulating Levels of Matrix Metalloproteinase-9 in Patients with Colorectal Cancer | Q74060110 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | diagnosis | Q16644043 |
| P304 | page(s) | 241-244 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Clinica Chimica Acta | Q5133740 |
| P1476 | title | Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood | |
| P478 | volume | 314 |
| Q46169786 | An electrophoretic method for the detection of chymotrypsin and trypsin activity directly in whole blood |
| Q35637026 | Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography |
| Q35146507 | Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. |
| Q64099958 | Cellular and Molecular Effects of High-Molecular-Weight Heparin on Matrix Metalloproteinase 9 Expression |
| Q42360792 | Gelatinases and physical exercise: A systematic review of evidence from human studies |
| Q33675870 | High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions |
| Q38161397 | Invasion and metastasis of renal cell carcinoma |
| Q42424812 | Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy |
| Q49118867 | Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas. |
| Q35936620 | Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications. |
| Q53351916 | Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables. |
| Q30879183 | Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats |
| Q78338951 | Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood |
| Q53303400 | Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer. |
| Q37639014 | TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model |
| Q42617736 | The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients |
| Q90262002 | Therapeutic Treatment with Abdominal Adipose Mesenchymal Cells Does Not Prevent Elastase-Induced Emphysema in Rats |
| Q44641391 | Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma |
| Q84600781 | Validating Sampling Methods for Measurement of Circulating Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 |
| Q46433289 | Whole blood assay for trypsin activity using polyanionic focusing gel electrophoresis |
| Q83578684 | YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma |
| Q36694831 | Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera |
Search more.